Target intelligence / Profile preview

Epithelial sodium channel alpha subunit mRNA (αENaC mRNA)

Target
αENaC mRNA
Molecular classification
Ion channel, Transporter
01

Overview

The "αENaC mRNA" refers to the messenger RNA transcript for the alpha subunit of the epithelial sodium channel (ENaC), which is a critical component of sodium-transporting epithelia in organs such as the kidney, lung, and colon[1][2][4][5]. The ENaC protein is a non-voltage-gated, amiloride-sensitive ion channel composed of three subunits: alpha (α), beta (β), and gamma (γ)[1][3][4]. The α subunit is essential for the assembly and function of the channel complex, enabling sodium ion reabsorption crucial for maintaining extracellular fluid volume and blood pressure[1][2][4]. The mRNA encoding this subunit (SCNN1A gene) is regulated by hormones such as aldosterone and vasopressin and serves as an important marker in both normal physiology and pathologies like hypertension and pseudohypoaldosteronism type 1[2][4][5]. However, as a molecular target, the focus is generally on the protein product rather than its mRNA; therefore, "αENaC mRNA" does not, by itself, function as a druggable receptor or ion channel but is relevant for understanding regulation and expression of the functional ENaC protein[1][3][4].

Other names
alpha-ENaC mRNASCNN1A mRNAα subunit of epithelial sodium channel mRNA
02

Mechanism of action

Blockade of sodium entry through the ENaC channel in epithelial cells, reducing sodium reabsorption

03

Biological functions

Sodium transportRegulation of sodium homeostasisBlood pressure regulationFluid balance
04

Disease associations

Pseudohypoaldosteronism type 1 (PHA-1)Hypertension (e.g., Liddle syndrome)Possibly cystic fibrosis and related pulmonary diseases (disordered airway surface liquid)
05

Safety considerations

Blockade of αENaC activity can cause hyperkalemia (excess potassium retention)Excessive αENaC activation can lead to hypertension and hypokalemia (seen in Liddle syndrome)
06

Interacting drugs

Amiloride

1 more in the full profile.

07

Biomarkers

αENaC mRNA/protein expression levels can serve as biomarkers for sodium handling or aldosterone responsivenessReduced αENaC function or expression is a marker in pseudohypoaldosteronism type 1 (PHA-1)

Beyond the preview

Go deeper on Epithelial sodium channel alpha subunit mRNA (αENaC mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial sodium channel alpha subunit mRNA (αENaC mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call